Login

Glaxosmithkline Pharmaceuticals Ltd.

₹2852.8

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Glaxosmithkline Pharmaceuticals Ltd.

₹2852.8

₹2852.8

-111.8 (-3.77%) - 3 May 2025 04:26 PM

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹48,328 Cr.
52 Week - High/Low ₹3,148/1,921
P/E Ratio 56.73
P/B Ratio 27.09
Enterprise Value ₹47,374 Cr.
ROE % 32.96
RSI Value 52.86
EMA 50 2700.47
EMA 200 2487.79
Net Profit 585 Cr.
Net Profit 3year growth 63.52 Cr.
Net Profit 3 year (back) 358 Cr.
Debt to Equity 0.0 %
EPS Growth TTM 13.02 %
Current Ratio 1.83 %
100 Day SMA 2,440 Rs.
200 Day SMA 2,566 Rs.
21 Day SMA 2,821 Rs.
50 Day SMA 2,710 Rs.
Book Value 105 Rs.
EV/EBITDA Ratio 38
QoQ EPS Growth -8 %
QoQ Operating Profit Growth -10 %
QoQ Sales Growth -5 %
Sales Latest Quarter 946 Cr.
YoY Sales Growth 18 %
Market Cap. ₹48,328 Cr.
52 Week - High/Low ₹3,148/1,921
P/E Ratio 56.26
P/B Ratio 27.19
Enterprise Value ₹47,373 Cr.
ROE % 33.43
RSI Value 52.86
EMA 50 2700.47
EMA 200 2487.79
Net Profit 590 Cr.
Net Profit 3year growth 13.35 Cr.
Net Profit 3 year (back) 358 Cr.
Debt to Equity 0.0 %
EPS Growth TTM 62.41 %
Current Ratio 1.84 %
100 Day SMA 2,440 Rs.
200 Day SMA 2,566 Rs.
21 Day SMA 2,821 Rs.
50 Day SMA 2,710 Rs.
Book Value 105 Rs.
EV/EBITDA Ratio 38
QoQ EPS Growth -9 %
QoQ Operating Profit Growth -11 %
QoQ Sales Growth -6 %
Sales Latest Quarter 949 Cr.
YoY Sales Growth 18 %
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.